Ovid Therapeutics (OVID) EBITDA Margin (2020 - 2026)
Ovid Therapeutics' EBITDA Margin came in at -2139.43% for Q2 2026, down 2060.12 percentage points from -79.30% a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ovid Therapeutics reported EBITDA Margin of -3681.36%, down 3064.89 percentage points year-over-year; for FY2025, it came in at -581.44%, up 10244.00 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +61.52 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -10825.44% in FY2024 (+4152.36 pp), -14977.81% in FY2023 (-11315.47 pp), -3662.33% in FY2022 (-3722.05 pp) and 59.72% in FY2021 (+702.68 pp).
- The five-year range for quarterly EBITDA Margin is -113929.35% (Q3 2022) to -79.30% (Q2 2025).
- Year-over-year, EBITDA Margin increased in four of the last seven quarters, with an average year-over-year change of +3495.88 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2023 (a gain of 103027.51 percentage points), and the weakest in Q1 2023 (a drop of 21223.58 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | -2,139.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,139.43% |
| Dec 31, 2025 | -1,709.75% |
| Sep 30, 2025 | -9,475.00% |
| Jun 30, 2025 | -79.30% |
| Mar 31, 2025 | -9,545.38% |
| Dec 31, 2024 | -13,897.37% |
| Sep 30, 2024 | -7,547.40% |
| Jun 30, 2024 | -12,052.66% |
| Mar 31, 2024 | -11,676.35% |
| Dec 31, 2023 | -12,709.86% |
| Sep 30, 2023 | -10,901.83% |
| Jun 30, 2023 | -18,713.33% |
| Mar 31, 2023 | -22,343.94% |
| Dec 31, 2022 | -25,903.05% |
| Sep 30, 2022 | -113,929.35% |
| Mar 31, 2022 | -1,120.36% |
| Mar 31, 2021 | 84.76% |
| Dec 31, 2020 | -377.13% |
| Sep 30, 2020 | -236.11% |
API Access
Ovid Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();